Breaking News

Nexelis Acquires GSK Vax Lab in Marburg

Enters into a 5-year strategic agreement to support the development of future GSK vaccine candidates.

By: Contract Pharma

Contract Pharma Staff

Nexelis, a provider of advanced assay development and laboratory testing services for infectious, oncologic, and metabolic diseases, has signed an asset purchase agreement with GlaxoSmithKline to acquire its GCLP-certified clinical bioanalytical lab in Marburg, Germany.

   The Clinical Laboratory Science (CLS) team of approximately 80 scientists and analysts, will be transferred to Nexelis. The CLS team will support the development of future GSK vaccine candidates through a 5-year strategic c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters